[Chronic Myeloid Leukemia with Variant E13a3 (b2a3) BCR-ABL1 As an ABL1 Tyrosine Kinase Inhibitor-Sensitive Subtype].
Rinshō ketsueki/Rinshou ketsueki（2021）
Key words
CML,RT-PCR,Variant BCR-ABL1,e13a3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined